Abstract: Detergent compositions which comprise from about 0.05 to about 95% by weight of a water-soluble ethoxylated amine having clay soil removal/anti-redeposition properties. These compounds are selected from ethoxylated monoamines, ethoxylated diamines, ethoxylated polyamines, ethoxylated amine polymers and mixtures thereof. In addition to the ethoxylated amines, the detergent compositions further comprise from about 1 to about 75% by weight of a nonionic, anionic, ampholytic, zwitterionic or cationic detergent surfactant, or mixture thereof. In addition to these detergent surfactants, the detergent composition can optionally comprise from 0 to about 80% by weight of a detergent builder.

Abstract: A peanut butter-filled snack product and the like is disclosed. This product includes an edible, heat stable, lubricious filling having a fat content of from about 40% to about 70% by weight. The filling is surrounded by a layer of dough comprising flour, water and at least about 21% fluid shortening by weight of the flour. The fluid shortening reduces oil migration during baking and storage so that the filling remains soft and lubricious.

Abstract: Temperable confectionery compositions having improved mouth melt and firmness control are disclosed herein. These compositions comprise a fat component having, by weight of the fat component:(a) at least about 70% SOS triglycerides;(b) from about 4 to about 20% combined SUU/UUU/SLS triglycerides;(c) about 8% or less SLS triglycerides;(d) about 9.5% or less SSO triglycerides;(e) about 2.5% or less SSS triglycerides; and(f) about 4% or less other glycerides;wherein S is stearic (St) or palmitic (P); and U is oleic (O) or linoleic (L). The St:P weight ratio is about 0.8 or less. These confectionery compositions preferably comprise a flavor component containing a chocolate flavor, to form chocolate compositions.

Abstract: Fluronaphthalene chromium tricarbonyls useful as hydrogenation catalysts are disclosed. Compositions suitable for hydrogenation comprise glycerides, nonglyceride esters, or mixtures thereof having polyunsaturated fatty acid residues, in particular polyunsaturated vegetable oils and those containing methyl linoleate. After being placed in a reactor having an inert inner surface, the polyunsaturated fatty acid residue-containing composition is contacted with hydrogen in the presence of the fluoronaphthalene chromium tricarbonyl to effect hydrogenation of the polyunsaturated fatty acid residues.

Abstract: A process for obtaining a temperable confectionery fat from palm oil is disclosed herein. This process comprises the steps of:(1) removing from palm oil by solvent fractionation one or more olein fractions to provide a first stearine fraction having less than about 10% combined SUU/UUU/SLS triglycerides by weight of the first stearine fraction;(2) removing from the first stearine fraction by solvent fractionation one or more olein fractions to provide a second stearine fraction having less than about 8% SSO triglycerides by weight of the second stearine fraction; and(3) removing from the second stearine fraction by solvent fractionation a third stearine fraction to provide a confectionery fat having less than about 2.5% SSS triglycerides by weight of the confectionery fat; wherein S is palmitic (P) or stearic (St); and U is oleic (O) or linoleic (L).The temperable confectionery fat obtained is particularly suitable for making chocolate having improved mouthmelt properties.

Abstract: alpha-Acylated glycerides having the formula: ##STR1## wherein each R.sup.1 is a C.sub.10 -C.sub.14 alkyl group and wherein each R.sup.2 is a C.sub.14 -C.sub.16 aliphatic group are disclosed. These alpha-acylated glycerides are useful as non-digestible fats in low calorie fat-containing food compositions.

Abstract: The 13,14-didehydro-15-oxo analogues of natural prostaglandins possess high cytoprotective activity and low diarrheogenic activity, low anti-hemostatic activity and low smooth muscle contraction activity.

Abstract: Chromium(III) tris-acetylacetonate, a coordinatively saturated, stable chromium(III) compound provides a dietary chromium supplement for humans and lower animals and is a useful hypoglycemic pharmaceutical agent for treating diabetes, especially when used in conjunction with insulin therapy.

Abstract: Novel ether carboxylates prepared from ketomalonate esters and diene compounds are disclosed. Detergent compositions incorporating the ether carboxylates can be prepared without use of phosphorus-containing detergent builder materials.

Abstract: A process for the catalytic oxidation of nonaromatic tertiary amines to the respective amine oxides is disclosed. An aqueous solvent system containing the tertiary amine is formed with an initial pH about equal to or greater than the pKa of the tertiary amine. This aqueous system is contacted with gaseous molecular oxygen at an oxygen partial pressure of at least about 50 psi and a temperature of at least about 80.degree. C. in the presence of certain octacyanomolybdate or iron (III) salts. The resulting oxidation converts the tertiary amine to the respective amine oxide in good yield.

Abstract: A composition, useful for producing analgesia in humans or lower animals, comprising a safe and effective amount of: an N-[(substituted pheynl)methyl]-cis-monounsaturated alkenamide pharmaceutically-acceptable salts thereof, or mixtures thereof; and a pharmaceutically-acceptable carrier. Preferably, these alkenamides are N-vanillyl-cis-monounsaturated alkenamides. Methods of treatment, comprising administering a safe and effective amount of these alkenamides, pharmaceutically-acceptable salts thereof, or mixtures thereof, include methods of parenteral, oral, and topical administration.

Abstract: Laundry detergent compositions essentially free of inorganic phosphate detergency builders and containing from about 3% to about 60% by weight of water-insoluble sodium aluminosilicate or organic detergency builder components and from about 0.5% to about 10% by weight hydroxyethylethylenediaminetriacetic acid or salts thereof have enhanced organic stain removal characteristics.

Abstract: Improved topical pharmaceutical compositions containing a pharmaceutically-active agent and the penetration enhancing agent 1-dodecylazacycloheptan-2-one are disclosed. This agent is used at selected levels in combination with certain C.sub.3 -C.sub.4 diols or a 1-substituted azacycloalkyl-2-one. This composition provides marked transepidermal and percutaneous delivery of the selected pharmaceutically-active agent. A method of treating certain pathologies and conditions responsive to the selected active, systemically or locally, is also disclosed.

Abstract: Methods for the treatment and prevention of diaper rash and diaper dermatitis caused by the prolonged contact of human skin with body waste are disclosed. The methods of the present invention employ the topical application of a minimum inhibitory concentration of a pharmaceutically-acceptable lipase-inhibiting agent to the area in need of such treatment, or the area where prevention is desired. The lipase-inhibiting agent is preferably a water-soluble metallic salt, such as ZnCl.sub.2, and is preferably applied in combination with a barrier-like vehicle. The effectiveness of these methods is surprising in light of the present confusion and controversy surrounding the actual causes of diaper rash, and the heretofore unrecognized role of lipase as a factor in the cause of diaper rash and diaper dermatitis.

Abstract: Topical pharmaceutical compositions containing a corticosteroid component and a penetration-enhancing vehicle are disclosed. The vehicle comprises a binary combination of a C.sub.3 -C.sub.4 diol and a "cell-envelope disordering compound". The vehicle provides marked transepidermal and percutaneous delivery of corticosteroids. A method of treating certain rheumatic and inflammatory conditions, systemically or locally, is also disclosed.

Abstract: Beverages especially suitable for carbonated soft drinks having a pH of from about 2.5 to about 6.5 are disclosed herein. These beverages have a flavor component which contains flavors selected from fruit flavors, botanical flavors and mixtures thereof. These beverages also contain mixtures of calcium and potassium cations, and preferably mixtures of calcium, magnesium and potassium cations, defined by a regression formula. Also included are edible acids selected from citric, malic/succinic and phosphoric acid, and mixtures thereof defined by a second regression formula. These beverages provide desirable flavor impressions in terms of sweetness, body and sourness with minimal bitter or salty off-notes. In addition, concentrates and syrups used to form these beverages have surprising stability against precipitation of insoluble salts.

Abstract: Water-soluble cationic polymers having clay soil removal/anti-redeposition properties, which comprise a polymer backbone, at least two M groups and at least one L-X group, wherein M is a cationic group attached to or integral with the backbone and contains an N+ positively charged center; X is a nonionic group selected from the group consisting of H, C.sub.1 -C.sub.4 alkyl or hydroxyalkyl ester or ether groups, or mixtures thereof; and L is a hydrophilic chain connecting groups M and X or connecting X to the polymer backbone. L also contains the polyoxyalkylene moiety --[(R'O).sub.m (CH.sub.2 CH.sub.2 O).sub.n ]--, wherein R' is C.sub.3 -C.sub.4 alkylene or hydroxyalkylene, m and n are numbers such that the moiety --(CH.sub.2 CH.sub.2 O).sub.n -- is at least about 50% by weight of said polyoxyalkylene moiety, and n is at least about 3. These cationic polymers are useful in detergent compositions.

Abstract: A method for preventing or reducing dermal irritation caused by thioglycolate depilatories by applying capsaicin and/or its salt(s) to at least a portion of the depilated area.

Abstract: Methylenealkanamide compounds, and pharmaceutically-acceptable salts thereof, of the formula: ##STR1## wherein X is O or S; R is straight or branched methylene substituted alkane having from 11 to 23 carbon atoms; R.sub.1 is H, OH, or OCH.sub.3 ; R.sub.2 is OH or a short-chain ester; and wherein at least one of R.sub.1 and R.sub.2 is OH or OCH.sub.3. Compositions, useful for producing analgesia in humans or lower animals, comprise a safe and effective amount of: a methylenealkanamide, pharmaceutically-acceptable salts thereof, or mixtures thereof; and a pharmaceutically-acceptable carrier. Preferably, these methylenealkanamides are N-vanillyl-methylenealkanamides. Methods of treatment, comprising administering a safe and effective amount of these methylenealkanamides, pharmaceutically-acceptable salts thereof, or mixtures thereof, include methods of parenteral, oral and topical administration.

Abstract: Alkadienamide compounds, and pharmaceutically-acceptable salts thereof, of the formula: ##STR1## wherein X is O or S; R is straight or branched diene having from 11 to 23 carbon atoms; R.sub.1 is H, OH, or OCH.sub.3 ; R.sub.2 is OH or a short-chain ester; and wherein at least one of R.sub.1 and R.sub.2 is OH or OCH.sub.3. Compositions, useful for producing analgesia in humans or lower animals, comprise a safe and effective amount of: an alkadienamide, pharmaceutically-acceptable salts thereof, or mixtures thereof; and a pharmaceutically-acceptable carrier. Preferably, these alkadienamides are N-vanillyl-alkadienamides. Methods of treatment, comprising administering a safe and effective amount of these alkadienamides, pharmaceutically-acceptable salts thereof, or mixtures thereof, include methods of parenteral, oral, and topical administration.